How to Follow a GLP-1 Review Back to Its Sources

A GLP-1 review can accurately cite a provider’s website and still leave you with the wrong impression. A starting price may exclude medication. “24/7 support” may describe customer service rather than a prescriber. A clinical trial may concern a specific injectable medicine, not the compounded formulation advertised beside its results. The useful question is not simply whether a sentence has a citation. It is whether the cited document supports that exact sentence, with its conditions intact.

This guide uses public documentation from CoreAge Rx, Ro, Enhance.MD, Sesame, Walgreens and Found to show how that check works. The pages were consulted October 19, 2026; that is a research date, not a claim that every document was updated then. These examples are documentary findings, not firsthand service tests or independent credential checks. Following the evidence means identifying who made a claim, what kind of source supports it, and where the record stops.

At a glance

A citation can document a contradiction: CoreAge Rx’s FAQ promises a 100% refund if a prescription is not approved, while its refund policy retains an applicable $50–$100 consultation fee.
Sources: [12] [6]
Membership is not medication: Ro lists a $39 first membership month, then $149 monthly or as low as $74 monthly equivalent with annual prepayment; medication costs are separate.
Sources: [5]
Read the billing interval: Enhance.MD labels Core plans as one through 12 months, but specifies billing intervals of four through 48 weeks.
Sources: [7]
Consulted does not mean newly updated: Walgreens’ consulted general terms state a last-update date of May 21, 2024. Reading them alongside 2026 commercial pages does not make the terms newly revised.
Sources: [9]
Regulatory evidence has a defined scope: FDA says compounded preparations are not FDA approved and recommends them when an individual’s medical needs cannot be met by an approved drug.
Sources: [1]

Start with the sentence, not the citation count

Choose one consequential sentence and break it into claims. “The program costs $74 a month and includes GLP-1 treatment” contains at least three: the amount, the payment schedule and what is included. Ro’s pricing page supports a membership price as low as $74 per month when an annual plan is prepaid. It separately says medication is not included. A citation to that page would not rescue a sentence that dropped either limitation.

A reliable evidence trail lets you reconstruct those distinctions without trusting the writer’s shorthand. Check the source passage, nearby qualifications and any separate policy it references. Ro also lists a $39 first month and an ongoing $149 monthly option. Those are different payment choices, not evidence that annual prepayment is mandatory. Our explanation of what public provider documents can prove develops this distinction between documenting an offer and verifying how it operates.

Match the question to the source—and keep its limits
Source type	What it can document	What it does not establish alone
Provider pricing page	Advertised charges, inclusions and stated conditions	An individual’s final checkout total
Provider terms or refund policy	Published responsibilities, deadlines and refund boundaries	Which conflicting statement staff will apply
Original clinical trial	Results for its studied population, product and protocol	A telehealth company’s treatment outcomes
FDA public guidance	Regulatory distinctions and agency recommendations	A provider-specific inspection or safety endorsement
Shipping or support page	Promised process, channels and stated timing	Actual delivery performance or immediate clinical access

Sources: [5] [13]

Keep the speaker attached to the claim

“Found says its compounded semaglutide is third-party tested” is materially different from “independent testing verifies Found’s medication.” Found’s page states that testing covers potency, purity and sterility before shipment. The consulted documentation does not identify the outside laboratory or provide certificates of analysis. Attribution preserves useful information without upgrading an assertion into an audit. Likewise, Ro discloses that members were paid for testimonials; those accounts should not become verified clinical outcomes.

Entity descriptions need the same discipline. CoreAge Rx’s legal footer assigns evaluations, treatment planning and prescribing to named independent professional entities, while DSO Fine Shrimp provides platform and administrative coordination. Enhance.MD similarly describes an administrative platform and says payment does not guarantee prescribing or dispensing. These statements help identify responsibilities. They do not independently verify professional licenses, prove the quality of care, or mean every clinician is a physician.

Sources: [15] [26] [18] [10]

Treat the consultation date as a boundary

A consultation date answers “When was this material examined?” It does not answer “When did the business last revise it?” Walgreens illustrates why this matters: the consulted general terms carry a May 21, 2024 update date, while commercial pages describe offers in 2026. A careful review preserves both facts rather than presenting all documentation as current to the research day. A future-dated offer also does not verify that a particular patient can redeem it.

The date matters when two pages disagree. Walgreens’ main weight-management page excludes Alabama and Louisiana from general availability. Its Bridge page additionally excludes Washington, DC, West Virginia and Oregon from the general program. Neither page’s presence in an October 19, 2026 research set resolves which list governs operational access. The useful conclusion is that the published lists differ and location-specific confirmation remains necessary—not that the writer can silently choose the broader coverage.

Sources: [9] [17] [30]

Follow a price through its footnotes

For a commercial claim, trace the medicine, formulation, route, presentation, period and additional charges. CoreAge Rx advertises compounded semaglutide from $79 per month and compounded tirzepatide from $129, with supplies and free shipping, while another homepage block says compounded GLP-1s start at $99. Its semaglutide safety page identifies subcutaneous injection. Those details document advertised offers, but do not establish the supply quantities or checkout conditions required for the lowest prices. Free shipping is not free treatment.

Billing units can change the meaning even when the dollar figure is clear. Enhance.MD’s injectable semaglutide Core page lists $249 per month for its one-month plan, billed every four weeks, with $50 off the first order. Its 12-month-labeled plan lists $212 per month, billed every 48 weeks, with an advertised 15% discount plus $100 off the first order. Do not turn four weeks into a calendar month, infer supply from the plan label, or invent an upfront total absent from the record.

Sources: [18] [16] [7]

Preserve conflicts instead of manufacturing certainty

Conflicting citations can be more informative than a clean-looking summary. CoreAge Rx’s FAQ says patients receive an automatic 100% refund if a provider does not approve a prescription. Its refund policy instead returns the refundable treatment or medication portion and retains an applicable $50–$100 consultation fee. The FAQ also explains charging before medical review, yet elsewhere says medication is billed when shipped. A review should show both tensions, not promise a refund or payment sequence it cannot establish.

Sesame offers another practical example. Its program page describes self-cancellation before the next billing cycle, whereas general terms require an email or telephone cancellation request at least 48 hours before renewal processing. Those terms also say the current paid period is not eligible for a prorated refund. The evidence supports asking which process applies and preserving written confirmation. It does not support equating cancellation with reimbursement or assuming a last-minute account action prevents a charge.

Sources: [12] [6] [27] [8]

Change evidence levels when the claim becomes clinical

Provider documentation can establish that a business markets a formulation; it cannot, by itself, establish the formulation’s clinical outcomes. CoreAge Rx advertises a product called Semaglutide Microdosing Therapy. Enhance.MD markets Elite as an injectable combination of semaglutide and tirzepatide. Neither product name makes evidence from a different studied treatment transferable. The central distinction in clinical trials versus company performance is whether a result actually measures the product and service being reviewed.

FDA guidance supplies a separate regulatory baseline: compounded preparations are not FDA approved and do not undergo FDA premarket review for safety, effectiveness and quality. That alone does not demonstrate clinical inequivalence. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. Approval belongs to a specific product, not a clinic or pharmacy; our guide to approved medicines and compounded preparations explains why these are separate evidence questions.

Sources: [14] [31] [1] [2] [3]

Trace the handoffs, not just the headline promise

A process citation should identify its milestone. Ro says eligibility is communicated within two days after the online visit. Its insurance documentation describes coordination typically taking one to three weeks, and says cash-pay prescriptions sent to Ro or partner pharmacies ship within a week once prescribed. These statements concern different stages. They do not combine into a guaranteed arrival date. A preferred pharmacy’s preparation estimate is also different from a home-delivery estimate.

Support language needs equally close reading. CoreAge Rx places “24/7 Provider Support” above text describing round-the-clock customer support. Walgreens separately offers pharmacy-expert chat, warns that a wait may be necessary, and prices weight-management follow-up chat visits at $49 each. Pharmacist-chat availability does not establish a zero fee or continuous prescriber access. For delivery problems, FDA explicitly advises not using an injectable GLP-1 that arrives warm or insufficiently refrigerated and contacting the provider or dispensing pharmacy; see how to read shipping evidence.

Sources: [26] [24] [22] [17] [25] [1]

Make unknowns useful without turning them into accusations

An unavailable detail is a research limit, not proof that a service does not exist. Found says it works exclusively with 503A compounding pharmacies, but the consulted documentation does not name those pharmacies. Enhance.MD’s FAQ names Tru Meds Rx, Strive Pharmacy and Pharmacy Hub; its terms list Rite-Away Pharmacy, Vios Compounding Pharmacy, TruMedsRx and others. The defensible question is which pharmacy would fill a particular prescription—not whether a missing or differing list proves improper dispensing.

Convert each material gap into a specific request before payment: the dispensing pharmacy’s name, the applicable refund policy, the exact first charge, or the clinical response process. Keep answers attached to the relevant program. For example, Enhance.MD allows a patient-selected pharmacy but says medication is then billed directly, while Found’s branded-drug terms allow a chosen pharmacy or eligible cash-pay access through NovoCare or LillyDirect. A general statement that patients may choose a pharmacy would conceal these channel-specific conditions.

Sources: [15] [11] [21] [19]

Questions & answers

What should I ask CoreAge Rx about its pharmacy policy?

Ask which rule applies before completing an order. Its FAQ says prescriptions must use the affiliated network and a local pharmacy cannot currently be used. Its terms instead allow a chosen pharmacy if requested through support@coreagerx.com before ordering. A citation to either page alone would hide the conflict.

Sources: [12] [20]

Does Ro’s insurance checker establish that I can receive treatment?

No. Ro describes the checker as collecting coverage information, not requesting treatment or writing prescriptions. Its treatment documentation separately requires a provider’s eligibility decision. The distinction matters because a favorable coverage report is neither a prescription nor confirmation that medication, membership and any other patient expenses are covered.

Sources: [23] [26]

Does Enhance.MD’s free intake mean no payment before consultation?

Not according to its FAQ. Although the initial intake is described as free, the FAQ places payment after the form and before a virtual meeting. Other process documentation describes laboratory testing before the consultation. Ask for the sequence applicable to your selected program; a free questionnaire does not establish a free clinical evaluation.

Sources: [4] [11]

Are all laboratory charges included with Success by Sesame?

No. The program limits included laboratory work to Quest Diagnostics, excluding its facilities in Arizona, Hawaii, North Dakota, New Jersey, New York, Oklahoma, Rhode Island, South Dakota and Wyoming. In those states, laboratory fees are additional. A review saying simply “labs included” would omit a substantial geographic and pharmacy-independent cost condition.

Sources: [27]

Does Walgreens’ no-subscription model mean follow-up is included?

No. Walgreens advertises initial weight-management visits starting at $49, with follow-up chat visits and additional video visits at $49 each. Medication is separate, and insurance is not currently accepted for these visits. The absence of a subscription describes the payment model, not an entitlement to unlimited included clinical care.

Sources: [17]

Does Found’s “with insurance” price mean insurance pays for compounded medication?

No. Found says those prices reflect coverage for clinical care; its billing consent makes patients responsible for compounded GLP-1 charges and prohibits submitting those amounts to insurance. Its insurance pathway also requires synchronous video visits before refills, with a visit copay typically around $30 on top of the plan price. Coverage and individual cost still require confirmation.

Sources: [19] [29] [28]

Our assessment

A strong GLP-1 review is valuable because it organizes scattered documentation, preserves qualifications and makes unresolved questions visible. It becomes less trustworthy when citations are used as decoration, provider assertions become independent findings, or clinical results are detached from the treatment actually studied. Public documents can support meaningful comparisons of prices, responsibilities and published policies, but cannot establish every checkout outcome, credential or treatment result. Follow the highest-stakes claims first: what you pay, who provides care, what medication is involved, and what happens if treatment is not approved. When the sources disagree, a transparent unresolved finding is more useful than an artificially confident answer.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

How to Follow a GLP-1 Review Back to Its Sources

At a glance

01Start with the sentence, not the citation count

02Keep the speaker attached to the claim

03Treat the consultation date as a boundary

04Follow a price through its footnotes

05Preserve conflicts instead of manufacturing certainty

06Change evidence levels when the claim becomes clinical

07Trace the handoffs, not just the headline promise

08Make unknowns useful without turning them into accusations